Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Clinical trial NCT03860844 · TERMINATED
Trial details
- NCT number
- NCT03860844
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2022-09-12
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.